Resultados de la búsqueda 601-610 of 4156 for coolsculpting

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...

  2. Medicina cardiovascular - Ensayos clínicos - Mayo Clinic

    Spontaneous coronary artery dissection (SCAD) is uncommon but important cause of acute coronary syndrome and sudden cardiac death. There is very little data ...

  3. Cirugía - Ensayos clínicos - Mayo Clinic

    The primary purpose of this study is to evaluate the effectiveness of non-fusion surgical treatment of Spinal Deformity Correction in Adolescent Idiopathic ...

  4. Kevin Kliner

    Page 1.

  5. Medicina cardiovascular - Ensayos clínicos - Mayo Clinic

    Spontaneous coronary artery dissection (SCAD) is uncommon but important cause of acute coronary syndrome and sudden cardiac death. There is very little data ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This results in killing tumor cells. Drugs used as chemotherapy, such as carboplatin and vincristine, work in different ways to stop the growth of tumor cells, ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This results in killing tumor cells. Drugs used as chemotherapy, such as carboplatin and vincristine, work in different ways to stop the growth of tumor cells, ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This results in killing tumor cells. Drugs used as chemotherapy, such as carboplatin and vincristine, work in different ways to stop the growth of tumor cells, ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study ia to determine the safety and tolerability of personalized neoantigen peptide administered in combination with pembrolizumab to ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Niraparib will be combined with trastuzumab, a HER2-targeted agent, to evaluate the safety and tolerability in patients with metastatic HER2 positive breast ...